STING1 and chronic kidney disease: In contrast, pretreatment of hVSMCs with H-151(STING inhibitors) or ruxolitinib (JAK-STAT inhibitor) significantly alleviates IFN-I response, premature senescence, and phenotypic switching in VSMCs induced by CKD serum (Bi et al., 2021).